Dr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatment
more
Stories about Health / Medicine
NESPRESSO WILL INVEST 20 MILLION USD IN DRC TO SUPPORT THE COFFEE GROWING COMMUNITY AND THE REVIVAL OF THE SPECIALTY COFFEE
Vevey, Switzerland (ots/PRNewswire) - Focusing on an increased sourcing of high-quality coffee, as well as implementing regenerative practices, gender equality programs and projects to increase access to healthcare and clean water. Nespresso aims to continue to support the local community and economy by investing 20 ...
moreARTCLINE successfully completes capital increases of EUR 4.4 million
Rostock, Germany (ots) - Today ARTCLINE GmbH announced the successful completion of two further capital increases. In addition to the founders, in particular family offices from Germany participated in the first capital increase of EUR 0.8 million. In addition, a convertible loan from investors was transferred to equity, so that a second capital increase of EUR 3.6 ...
moreFennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
Research Triangle Park, N.C. and Uxbridge, England (ots/PRNewswire) - Agreement pairs Norgine's commercial expertise and leading European footprint with PEDMARQSI™, the first and only approved therapy in the European Union and U.K. for reducing the risk of cisplatin-induced hearing loss in pediatric patients with ...
moreResearch Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘
moreLTS Lohmann Therapie-Systeme AG
First product based on LTS’ Sorrel(TM) wearable drug delivery platform launched in the US
moreHearing loss company Acousia announces first patient enrolled in its Phase 2 PROHEAR-Study
Tübingen, Germany (ots) - Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, just announced the randomization of the first patient for the PROHEAR-Study. The PROHEAR-Study is a placebo-controlled, Phase 2a study with split-body design, which investigates the otoprotective efficacy ...
moreBiomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapy
moreSHL Medical partners with SteriPack Group to set up final assembly service
moreIntuitive Surgical Deutschland GmbH
Intuitive’s da Vinci Single-Port Surgical System Receives CE Mark / da Vinci SP approved for use in Europe across multiple procedures
Sunnyvale, Calif. (ots) - Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced that the da Vinci Single-Port (SP) surgical system has received CE mark approval for use in Europe for endoscopic abdominopelvic, thoracoscopic, transoral ...
moreAcousia Therapeutics attracts new investor on its path to make hearing loss a treatable disease
Tübingen (ots) - - German pioneer biotech accelerates hearing loss solution development with fresh capital boost Acousia Therapeutics GmbH, a clinical-stage biotech company developing drug candidates against acute and chronic forms of hearing loss, proudly announces Esperante Ventures as the latest addition to its esteemed group of investors. The infusion of fresh ...
moreRelaunch Gipsbomber - SOS-emergency-call-centre launches winter season
Innsbruck (ots) - Flights from Innsbruck to BENELUX are already planned and will bring injured holidaymakers home. After its launch last winter, the "Gipsbomber" is experiencing a real relaunch thanks to the SOS-Emergency-Call-Centre. "For over 17 years, there was no alternative to the DASH7 for transporting injured holidaymakers home, but now it's the Dornier 328-100 ...
moreLTS Lohmann Therapie-Systeme AG
LTS receives $4.3 Million grant for the development of contraceptive Microneedle Array Patches
moreCES award-winning e-exoskeleton specialist German Bionic presents the Apogee+ power suit for the health sector, in Las Vegas
Berlin (ots) - Recognized with this year’sCES “Best of Innovation” Award in the Wearable Technologies category, Berlin-based robotics and wearable tech specialist German Bionic is back in Las Vegas in 2024 with its latest e-exoskeleton, the Apogee+ power suit. The device is specifically developed to provide ...
moreLTS Lohmann Therapie-Systeme AG
LTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patches
moreTakeda Pharma Vertrieb GmbH & Co. KG
The European Commission Approves Label Update for TAKHZYRO® (lanadelumab), Expanding Its Use to a Broader Group of Paediatric Patients with Recurrent Attacks of Hereditary Angioedema (HAE)
Zurich (ots/PRNewswire) - - TAKHZYRO® is the First Routine Prevention Treatment of HAE Approved in the EU for Patients Under the Age of Six. - The therapeutical indication for TAKHZYRO® has been extended to patients aged 2 years and older.1 - Offers a New Preventative Treatment Option for young HAE patients with ...
moreBehaVR and Fern Health Merge To Form RealizedCare, Launch Digital Care Management Platform to Unlock the Value of Digital Therapeutics
NASHVILLE, Tenn., Aachen, Germany (ots) - The merger will accelerate a new digitally-powered care management solution for chronic pain and beyond; Pharmaceutical company Grünenthal becomes the largest investor in the combined enterprise BehaVR, a pioneering force in digital therapeutics (DTx) experiences, and Fern ...
moreBehaVR and Fern Health Merge To Form RealizedCare, Launch Digital Care Management Platform to Unlock the Value of Digital Therapeutics
NASHVILLE, Tenn., Aachen, Germany (ots) - The merger will accelerate a new digitally-powered care management solution for chronic pain and beyond; Pharmaceutical company Grünenthal becomes the largest investor in the combined enterprise BehaVR, a pioneering force in digital therapeutics (DTx) experiences, and Fern ...
moreSHL Medical achieves EcoVadis® Silver Medal and sets ambitious science-based climate targets
moreBiomay Announces Expansion of GMP-Facilities to Offer mRNA Manufacturing and Aseptic Filling Services
moreSuperVista AG expands strategically with new 360-degree B2B offering for the entire ophthalmic optics sector
moreSHL Medical and Lifecore Biomedical enter co-marketing partnership agreement
moreWorld Health Summit kicks off in Berlin / Experts from around the world meet at the most important forum on global health
Berlin (ots) - The World Health Summit 2023, the world's leading meeting for global health, began Sunday morning in Berlin. From October 15 to 17, international representatives from politics, science, business and civil society will discuss crucial issues in global health under the motto "A Defining Year for Global ...
moreHearing Loss Company Acousia Therapeutics Green Lighted for Game-Changing Phase 2 Trial
Tübingen, Germany (ots/PRNewswire) - Acousia Therapeutics, a pioneer clinical-stage biotech company focused on the development of novel drug therapies for the prevention and treatment of acute and chronic forms of hearing loss, received approval from the German regulatory authorities (BfArM) for its groundbreaking Phase 2 clinical trial of the etiology-agnostic ...
moreHearing Loss Company Acousia Therapeutics Green Lighted for Game-Changing Phase 2 Trial
Tübingen, Germany (ots) - Acousia Therapeutics, a pioneer clinical-stage biotech company focused on the development of novel drug therapies for the prevention and treatment of acute and chronic forms of hearing loss, received approval from the German regulatory authorities (BfArM) for its groundbreaking Phase 2 clinical trial of the etiology-agnostic otoprotectant ...
moreLanserhof Group will open its first health resort in Spain following an agreement with AltamarCAM and Inbest-GPF
Madrid/Hamburg (ots) - AltamarCAM and Inbest-GPF, together with the Austrian Group Lanserhof, join forces to invest 100 million euros in the wellness sector. Global asset manager AltamarCAM Partners and Spanish real estate group Inbest-GPF have partnered with Lanserhof Group, a leader in preventive medicine and ...
moreTakeda Pharma Vertrieb GmbH & Co. KG
Takeda Receives Positive CHMP Opinion Recommending Approval of Lanadelumab for Routine Prevention of Recurrent Attacks of Hereditary Angioedema (HAE) in Patients Aged 2 years and Older
Zurich (ots/PRNewswire) - - If Approved, Lanadelumab Will be the First Long-Term Prophylactic Treatment of HAE Available in the EU for Patients Under the Age of Six. - Positive Opinion Based on Pivotal Study SHP643-301, Evaluating the Safety Profile and Pharmacokinetics (PK) of Lanadelumab, in Combination with ...
moreNorgine Strengthens Senior Leadership with the Appointment of Saulo Martiniano as Chief Operating Officer
Amsterdam (ots/PRNewswire) - Norgine, a leading European specialist pharmaceutical company dedicated to improving the lives of patients, is pleased to announce the appointment of Saulo Martiniano as its new Chief Operating Officer (COO). Saulo joins Norgine with a wealth of experience and a unique blend of ...
moreWorld Health Summit 2023 with 20 ministers from all over the world in Berlin from October 15-17 / Press accreditation open for the world’s leading global health conference
Berlin (ots) - The World Health Summit 2023 from October 15-17 in Berlin will bring together the most prominent names in global health from all sectors in all regions of the world. Speakers will include government ministers from over 10 countries, renowned scientists, and high-level representatives from the private ...
moreOD-OS GmbH at ESCRS 2023: Recent MDR certification of Navilas® underlines its advanced standard in retina lasers and opens path to new developments
more
Previous12345678910Next